Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B
Biological barriers remain a major obstacle for the development of innovative therapeutics. Depending on a disease's pathophysiology, the involved tissues, cell populations, and cellular components, drugs often have to overcome several biological barriers to reach their target cells and become...
Saved in:
Main Authors: | Emre Basar (Author), Henry Mead (Author), Bennett Shum (Author), Ingrid Rauter (Author), Cihan Ay (Author), Adriane Skaletz-Rorowski (Author), Norbert H. Brockmeyer (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement
by: Patrick Ahaus, et al.
Published: (2022) -
Age specific evaluation of sexual behavior, STI knowledge and infection among asymptomatic adolescents and young adults
by: A. Skaletz-Rorowski, et al.
Published: (2020) -
Hemophilia
Published: (2012) -
HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in Germany
by: M. Uhrmacher, et al.
Published: (2022) -
Hemophilia Recent Advances
Published: (2019)